InvestSMART

Medical Developments International Limited (ASX: MVP) - Announcements

Current share price for MVP : $0.505 0.005 (0.98%)+

ASX company news and announcements for Medical Developments International Limited (MVP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Medical Developments International Limited (MVP) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Medical Developments International Limited (MVP), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Medical Developments International Limited (MVP)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$57 Change of Director's Interest Notice - P Townsend 25 Sep 2025 8:23AM $0.660 $0.505 fallen by 23.48%
$57 Board Chair Transition 22 Sep 2025 4:49PM $0.680 $0.505 fallen by 25.74%
$57 2025 Annual Report 8 Sep 2025 9:44AM $0.575 $0.505 fallen by 12.17%
$57 2025 Notice of Annual General Meeting 8 Sep 2025 9:43AM $0.575 $0.505 fallen by 12.17%
$57 Corporate Governance Statement 2025 8 Sep 2025 9:40AM $0.575 $0.505 fallen by 12.17%
$57 Appendix 4G 8 Sep 2025 9:39AM $0.575 $0.505 fallen by 12.17%
$57 MVP Announces FY25 Full Year Results 21 Aug 2025 8:57AM $0.635 $0.505 fallen by 20.47%
$57 FY25 Full Year Results 21 Aug 2025 8:57AM $0.635 $0.505 fallen by 20.47%
$57 FY25 Full Year Results Investor Presentation 21 Aug 2025 8:55AM $0.635 $0.505 fallen by 20.47%
$57 Date of AGM and Closing Date for Director Nominations 20 Aug 2025 12:18PM $0.700 $0.505 fallen by 27.86%
$57 FY25 Full Year Results Announcement Details 13 Aug 2025 9:27AM $0.740 $0.505 fallen by 31.76%
$57 Appendix 4C and Quarterly Activity Report - 30 June 2025 31 Jul 2025 10:03AM $0.660 $0.505 fallen by 23.48%
$57 Notification regarding unquoted securities - MVP 2 Jun 2025 5:39PM $0.670 $0.505 fallen by 24.63%
$57 Initial Director's Interest Notice 30 May 2025 10:04AM $0.650 $0.505 fallen by 22.31%
$57 Director Appointment and Resignation 30 May 2025 9:10AM $0.650 $0.505 fallen by 22.31%
$57 Appendix 4C and Quarterly Activity Report - 31 March 2025 29 Apr 2025 9:19AM $0.465 $0.505 risen by 8.60%
$57 Initial Director's Interest Notice - M. Fladrich 1 Apr 2025 9:51AM $0.555 $0.505 fallen by 9.01%
$57 Appointment of Director - Mark Fladrich 21 Mar 2025 12:26PM $0.645 $0.505 fallen by 21.71%
$57 FY25 Half Year Announcement 20 Feb 2025 8:22AM $0.765 $0.505 fallen by 33.99%
$57 FY25 Half Year Presentation 20 Feb 2025 8:21AM $0.765 $0.505 fallen by 33.99%
$57 FY25 Half Year Report (including Appendix 4D) 20 Feb 2025 8:21AM $0.765 $0.505 fallen by 33.99%
$57 FY25 Half Year Results Announcement Details 12 Feb 2025 12:47PM $0.780 $0.505 fallen by 35.26%
$57 Appendix 4C and Quarterly Activity Report -31 December 2024 31 Jan 2025 8:18AM $0.440 $0.505 risen by 14.77%
$57 Final Director's Interest Notice M. Sontrop 23 Dec 2024 10:42AM $0.405 $0.505 risen by 24.69%
$57 MVP Investor Presentation - Bell Potter Conference 20 Nov 2024 10:53AM $0.425 $0.505 risen by 18.82%

26 - 50 of 619 results

Page 2 of 25

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.